Table 1 Baseline laboratory indicators, medication, vessel and DCB characteristics by tertiles of the TyG index
From: Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Variable | Tertile 1 (n = 52) | Tertile 2 (n = 52) | Tertile 3 (n = 53) | P value |
|---|---|---|---|---|
TyG index | 8.2 ± 0.2 | 8.7 ± 0.1 | 9.4 ± 0.4 | < 0.001 |
Age,years | 64.1 ± 10.3 | 58.8 ± 12.3 | 62.0 ± 10.6 | 0.056 |
Body mass index,kg/m2 | 23.8 ± 2.9 | 24.9 ± 3.2 | 25.0 ± 3.0 | 0.059 |
LDL-C,mmol/L | 2.7 ± 1.0 | 2.7 ± 1.0 | 2.9 ± 1.3 | 0.547 |
TC,mmol/L | 4.0 ± 1.1 | 4.1 ± 1.1 | 4.4 ± 1.4 | 0.143 |
HDL-C,mmol/L | 1.1 ± 0.3 | 1.0 ± 0.3 | 1.0 ± 0.3 | < 0.001 |
SCr,umol/L | 75.6 ± 21.8 | 91.4 ± 85.7 | 79.1 ± 20.6 | 0.272 |
LVEF,% | 63.0 ± 9.8 | 63.8 ± 8.9 | 63.3 ± 10.3 | 0.916 |
triglyceride,mg/dL | 83.3 ± 18.7 | 131.1 ± 23.7 | 206.5 ± 91.0 | < 0.001 |
Fasting blood glucose,mg/dL | 94.4 ± 17.0 | 99.0 ± 15.5 | 134.6 ± 45.8 | < 0.001 |
Hemoglobin A1C,% | 6.5 ± 1.1 | 6.6 ± 1.5 | 7.3 ± 1.6 | 0.007 |
Reference vessel diameter,mm | 2.5 ± 0.7 | 2.6 ± 0.8 | 2.5 ± 0.6 | 0.521 |
Maximum drug-coated balloon diameter,mm | 2.6 ± 0.4 | 2.7 ± 0.4 | 2.6 ± 0.5 | 0.798 |
Maximum drug-coated pressure, atm | 10.8 ± 2.0 | 10.3 ± 2.4 | 10.8 ± 3.0 | 0.532 |
Men,n(%) | 39 (75.0%) | 41 (78.8%) | 42 (79.2%) | 0.847 |
ACS,n(%) | 43 (82.7%) | 44 (84.6%) | 45 (84.9%) | 0.945 |
Hypertension,n(%) | 33 (63.5%) | 34 (65.4%) | 36 (67.9%) | 0.89 |
Diabetes mellitus,n(%) | 16 (30.8%) | 17 (32.7%) | 33 (62.3%) | 0.001 |
Current smoker,n(%) | 19 (36.5%) | 14 (26.9%) | 14 (26.4%) | 0.445 |
ACEI/ARB/ARNI,n(%) | 29 (55.8%) | 31 (59.6%) | 30 (56.6%) | 0.917 |
Beta-blocker,n(%) | 34 (65.4%) | 30 (57.7%) | 47 (88.7%) | 0.001 |
Statins,n(%) | 52 (100.0%) | 52 (100.0%) | 52 (98.1%) | 0.373 |
Ticagrelor,n(%) | 36 (69.2%) | 36 (69.2%) | 44 (83.0%) | 0.177 |
Clopidogrel,n(%) | 15 (28.8%) | 16 (30.8%) | 9 (17.0%) | 0.213 |
Aspirin,n(%) | 50 (96.2%) | 50 (96.2%) | 50 (94.3%) | 0.873 |
Type of predilation drug | Â | Â | Â | 0.419 |
Cutting balloon,n(%) | 21 (40.4%) | 13 (25.0%) | 15 (28.3%) | Â |
Semicompliant balloon,n(%) | 23 (44.2%) | 23 (44.2%) | 27 (50.9%) | Â |
Noncompliant balloon,n(%) | 2 (3.8%) | 5 (9.6%) | 2 (3.8%) | Â |
Both/All,n(%) | 6 (11.5%) | 11 (21.2%) | 9 (17.0%) | Â |
Type of target vessel | Â | Â | Â | 0.198 |
LAD,n(%) | 25 (48.1%) | 24 (46.2%) | 25 (47.2%) | Â |
LCX,n(%) | 17 (32.7%) | 16 (30.8%) | 10 (18.9%) | Â |
RCA,n(%) | 5 (9.6%) | 11 (21.2%) | 12 (22.6%) | Â |
Branch,,n(%) | 5 (9.6%) | 1 (1.9%) | 6 (11.3%) | Â |
Post-procedure TIMI grade 3 flow,n(%) | 51 (98.1%) | 51 (98.1%) | 52 (98.1%) | 1.000 |
Drug coated balloon diameter to vessel diameter ratio(1:1),n(%) | 12 (23.1%) | 12 (23.1%) | 12 (22.6%) | 0.998 |